Literature DB >> 29205797

Stereotactic ablative radiotherapy for hepatocellular carcinoma: History, current status, and opportunities.

Jeffrey Meyer1, Amit G Singal2.   

Abstract

A variety of surgical and other local-regional approaches to the management of hepatocellular carcinoma (HCC) are in clinical use. External beam radiation therapy is a relative newcomer to the portfolio of treatment options. Advances in planning and delivery of radiation therapy, developing in parallel with and inspiring changing paradigms of tumor management in the field of radiation oncology, have led to growing interest in radiation therapy as a viable treatment option for HCC as well as other liver tumors. In this review, we discuss these advances, current trends in liver radiotherapy, as well as avenues of future clinical and basic research. Liver Transplantation 24 420-427 2018 AASLD.
© 2017 by the American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Year:  2018        PMID: 29205797     DOI: 10.1002/lt.24991

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  6 in total

1.  Locoregional therapy as a bridge to liver transplantation for hepatocellular carcinoma within Milan criteria: from a transplant oncology viewpoint.

Authors:  Taizo Hibi; Yasuhiko Sugawara
Journal:  Hepatobiliary Surg Nutr       Date:  2018-04       Impact factor: 7.293

Review 2.  Health economic evaluation of stereotactic body radiotherapy (SBRT) for hepatocellular carcinoma: a systematic review.

Authors:  Haiyin Wang; Chunlin Jin; Liang Fang; Hui Sun; Wendi Cheng; Shanlian Hu
Journal:  Cost Eff Resour Alloc       Date:  2020-01-10

Review 3.  Stereotactic Radiotherapy for Hepatocellular Carcinoma, Radiosensitization Strategies and Radiation-Immunotherapy Combination.

Authors:  Luis A Pérez-Romasanta; Elisabet González-Del Portillo; Ana Rodríguez-Gutiérrez; Ángela Matías-Pérez
Journal:  Cancers (Basel)       Date:  2021-01-07       Impact factor: 6.639

Review 4.  The effects of several postoperative adjuvant therapies for hepatocellular carcinoma patients with microvascular invasion after curative resection: a systematic review and meta-analysis.

Authors:  Jiarui Yang; Hao Liang; Kunpeng Hu; Zhiyong Xiong; Mingbo Cao; Zhaozhong Zhong; Zhicheng Yao; Meihai Deng
Journal:  Cancer Cell Int       Date:  2021-02-06       Impact factor: 5.722

5.  Comparison of clinical outcome between stereotactic body radiotherapy and radiofrequency ablation for unresectable hepatocellular carcinoma.

Authors:  Ren Ji; Kelvin K Ng; Wenqi Chen; Weihong Yang; Hongtao Zhu; Tan-To Cheung; Chi-Leung Chiang; Tiffany C L Wong; Feng-Ming Kong; G Wu; Chung-Mau Lo
Journal:  Medicine (Baltimore)       Date:  2022-01-28       Impact factor: 1.889

Review 6.  Hepatocellular Carcinoma-How to Determine Therapeutic Options.

Authors:  Neil Mehta
Journal:  Hepatol Commun       Date:  2020-01-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.